Rolek Wealth Management LLC Invests $208,000 in Oscar Health, Inc. (NYSE:OSCR)

Rolek Wealth Management LLC acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 15,502 shares of the company's stock, valued at approximately $208,000. Oscar Health comprises 0.2% of Rolek Wealth Management LLC's investment portfolio, making the stock its 11th biggest position.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Hennessy Advisors Inc. grew its holdings in shares of Oscar Health by 550.3% during the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the last quarter. Harbor Capital Advisors Inc. boosted its position in Oscar Health by 39.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 128,167 shares of the company's stock valued at $1,723,000 after purchasing an additional 36,577 shares during the period. ORG Wealth Partners LLC bought a new position in Oscar Health during the 4th quarter worth $100,000. Nordea Investment Management AB acquired a new stake in Oscar Health in the fourth quarter worth $1,056,000. Finally, JPMorgan Chase & Co. lifted its stake in Oscar Health by 68.5% in the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company's stock valued at $48,977,000 after buying an additional 938,742 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Insider Buying and Selling

In other news, insider Mario Schlosser sold 6,516 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $117,809.28. Following the completion of the sale, the insider now owns 81,962 shares in the company, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Steven Wolin sold 19,580 shares of the firm's stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $354,006.40. Following the sale, the chief operating officer now directly owns 102,598 shares of the company's stock, valued at approximately $1,854,971.84. This represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have bought 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. 25.11% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Jefferies Financial Group initiated coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price target for the company. Bank of America cut shares of Oscar Health from a "neutral" rating to an "underperform" rating and decreased their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, UBS Group assumed coverage on Oscar Health in a report on Monday, October 7th. They set a "neutral" rating and a $23.00 price target on the stock. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $21.56.

Oscar Health Price Performance

Shares of Oscar Health stock traded up $0.18 on Thursday, hitting $16.44. The company had a trading volume of 2,580,409 shares, compared to its average volume of 3,111,636. Oscar Health, Inc. has a 52 week low of $11.38 and a 52 week high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $4.07 billion, a PE ratio of -274.00, a PEG ratio of 0.63 and a beta of 1.70. The business has a 50-day simple moving average of $15.19 and a 200-day simple moving average of $16.81.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same period in the previous year, the business posted ($0.29) earnings per share. The business's revenue for the quarter was up 68.3% compared to the same quarter last year. Research analysts expect that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.